hydralazine has been researched along with Heart Defects, Congenital in 3 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olson-Chen, C | 1 |
| Seligman, NS | 1 |
| Artman, M | 1 |
| Parrish, MD | 1 |
| Graham, TP | 1 |
| Fripp, RR | 1 |
| Gewitz, MH | 1 |
| Werner, JC | 1 |
| Whitman, V | 1 |
| Rashkind, WJ | 1 |
2 reviews available for hydralazine and Heart Defects, Congenital
| Article | Year |
|---|---|
Hypertensive Emergencies in Pregnancy.
Topics: Antihypertensive Agents; Cesarean Section; Chronic Disease; Congenital Abnormalities; Emergencies; E | 2016 |
Congestive heart failure in childhood and adolescence: recognition and management.
Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Ele | 1983 |
1 other study available for hydralazine and Heart Defects, Congenital
| Article | Year |
|---|---|
Oral hydralazine in patients with pulmonary vascular disease secondary to congenital heart disease.
Topics: Administration, Oral; Cardiac Output; Child; Child, Preschool; Female; Heart Defects, Congenital; He | 1981 |